Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...

BOSTON - Bain Capital Specialty Finance , Inc. (NYSE:BCSF), a business development company with a market capitalization of $1 ...

(Reuters) -Bain Capital ... Bain Capital said in the letter. Bain added that it is only interested in acquiring the shares it doesn't already own and has no intention of selling the shares it ...

US-based Bain Capital has increased its takeover bid for Australian wealth manager Insignia Financial to A$2.87bn ($1.76bn). The offer matches the indicative non-binding buyout offer made last ...

The American investment company Bain Capital is considering the sale of Italmatch Chemicals SpA, an Italian manufacturer of specialty chemicals. This is reported in a press release from Bain Capital.

SYDNEY—Insignia Financial on Monday said Bain Capital has matched a US$1.8 billion takeover offer by CC Capital Partners, intensifying a tussle for control of the Australian wealth manager.

CC Capital sweetened its bid to A$4.60 per share, Insignia said in a statement Friday. That tops its earlier approach and a separate offer from Bain Capital by 7%. The shares added as much as 4.8% ...

The provider of highly-engineered processing equipment and solutions will sell a 51% stake in the injection molding and extrusion business for $287 million.